Ticker Symbol: NURO
Neurometrix Inc.
$7.40 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001289850
Company Profile
NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of disorders involving the nervous system. The Company has three commercial products. DPNCheck® is a diagnostic device that provides rapid, point-of-care detection of peripheral neuropathies. ADVANCE® is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of focal neuropathies. Quell® is a wearable neurostimulation device indicated for symptomatic relief of chronic pain that is available over-the-counter.
Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Standard Industrial Classification Code (SIC code): 3841
Address: 1000 Winter St
Website: www.neurometrix.com
CEO: Shai Gozani
Tags:
- Health Technology
- Medical Specialties
- Manufacturing
- Surgical and Medical Instrument Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $0.66
Change:
-$0.04
(
-6.57%)
Days Range: $0.66 - $0.71
Beta: 1.16
52wk. High: $2.18
52wk. Low: $0.60
Ytd. Change -58.99%
50 Day Moving Average: $0.67
200 Day Moving Average: $0.94
Shares Outstanding: 8585019
Valuation
Market Cap: 568.7M
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A